Skip to content

CYCLE Pilot Randomized Trial

CYCLE Pilot: A Pilot Randomized Study of Early Cycle Ergometry Versus Routine Physiotherapy in Mechanically Ventilated Patients

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02377830
Acronym
CYCLE Pilot
Enrollment
113
Registered
2015-03-04
Start date
2015-03-31
Completion date
2018-12-31
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensive Care Unit Acquired Weakness, Critical Care, Mechanical Ventilation, Respiratory Failure

Brief summary

Background: Patients in the intensive care unit (ICU) are the sickest in hospital, and need advanced life-support. Survivors of critical illness are very weak and disabled. Up to 1 in 4 have severe leg weakness impairing their quality of life for as long as 5 years after ICU discharge. In-bed cycling involves use of special equipment that attaches to a patient's hospital bed, allowing them gentle exercise while in the ICU. Methods: Adult patients admitted to the ICU who need a breathing machine and are expected to survive their ICU stay are eligible. Patients will randomly receive 30 minutes of in-bed cycling each day they are in the ICU or routine physiotherapy, both delivered by specially trained physiotherapists. Outcomes: Feasibility: The investigators will study whether patients can cycle on most days of their ICU stay, whether patients and their families agree to be a part of the study, and whether investigators can systematically assess patients' strength. Relevance: Effective methods of physiotherapy are needed for critically ill patients to minimize muscle weakness, speed recovery, and improve quality of life. This pilot randomized study is the second of several future larger studies about in-bed cycling in the ICU. Our pilot work includes CYCLE Pilot and CYCLE Vanguard. CYCLE Pilot is an external pilot and enrolled 66 patients from 3/2015 to 6/2016. CYCLE Vanguard is an internal pilot and enrolled 47 patients from 11/2016 to 3/2018. CYCLE Vanguard patients will be analyzed in the main CYCLE RCT (NCT03471247).

Interventions

DEVICEIn-bed cycle ergometer (Restorative Therapies RT300 Supine)

activities to assist with optimizing airway clearance and respiratory function, and, based on the patient's alertness and medical stability, activities to maintain or increase limb range of motion and strength, in- and out of bed mobility, and ambulation

Sponsors

St. Joseph's Healthcare Hamilton
CollaboratorOTHER
Hamilton Health Sciences Corporation
CollaboratorOTHER
Technology Evaluation in the Elderly Network / Canadian Frailty Network
CollaboratorUNKNOWN
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Ontario Lung Association
CollaboratorOTHER
Canadian Respiratory Research Network
CollaboratorUNKNOWN
McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults admitted to a medical-surgical ICU within the 1st 4 days of mechanical ventilation (MV) and 1st 7 days of ICU, and * could ambulate independently before hospital admission.

Exclusion criteria

* Acute condition impairing patients' ability to cycle (e.g., leg fracture), * proven or suspected neuromuscular weakness affecting the legs (e.g., stroke or Guillain-Barré syndrome), * unable to follow commands in English pre-ICU, * temporary pacemaker, * expected hospital mortality \>90%, * unable to fit the bike, palliative goals of care, or persistent therapy exemptions in the 1st 4 days of MV (e.g., cardiorespiratory instability, active major bleeding)

Design outcomes

Primary

MeasureTime frame
Patient accrual2 years

Secondary

MeasureTime frameDescription
Cycling protocol violations (% cycling protocol violations)2 years% cycling protocol violations
Outcome measure ascertainment (% outcomes measured in hospital)2 years% outcomes measured in hospital
Blinded outcome measures at hospital discharge (% outcomes at hospital discharge measured by blinded outcome assessors)2 years% outcomes at hospital discharge measured by blinded outcome assessors
Physical Function Test for ICU (PFIT) at ICU awakening, ICU discharge, 3-days post-ICU discharge (CYCLE Vanguard only) and hospital dischargeFrom study admission to approximately 5, 12, 15 and 30 days, on average, respectivelyPatients complete 4 activities: arm and leg strength, ability to stand, and step cadence. Scores range from 0 to 10, with higher scores = better function
Quadriceps strength at ICU and hospital discharge (Force measured in Kg and in Newtons on a continuous scale)From study admission to approximately 12 and 30 days, on average, respectivelyThe patient exerts a force against a small strain gauge that fits in the examiner's hand. .
2 minute walk test at ICU discharge, 3-days post-ICU (CYCLE Vanguard only), and hospital dischargeFrom study admission to approximately 12 and 30 days, on average, respectivelyMaximum distance walked in 2 minutes measured in metres on a continuous scale
Muscle strength at ICU awakening, ICU discharge, 3-days post-ICU discharge (CYCLE Vanguard only), and hospital dischargeFrom study admission to approximately 5, 12, 15 and 30 days, on average, respectivelyManual muscle testing using the Medical Research Council (MRC) Scale. The patient exerts a force against the examiner's resistance. Each muscle is assessed on a 6-point MRC scale (0=no contraction; 5=contraction sustained against maximal resistance).

Other

MeasureTime frameDescription
Katz Activities of Daily Living Scale at ICU and hospital dischargeFrom study admission to approximately 12 and 30 days, on average, respectivelyThe patient's ability to complete 6 tasks: bathing, dressing, toileting, feeding, continence, and bed mobility. A rater assesses whether the patient is dependent or independent according to pre-specified criteria.
Euro-QOL 5DLFrom study admission to approximately 12 and 30 days, on average, respectively5 question self-administered, preference-based instrument to measure mobility, self-care, usual activities, pain, and anxiety/ depression, as well as a global assessment of health

Countries

Australia, Canada, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026